Not finding it? Sign in to also search OpenAlex live.
-
P0244 / #1602: ANTI-XA VERSUS TIME-GUIDED ANTICOAGULATION STRATEGY IN EXTRACORPOREAL MEMBRANE OXYGENATION: A SYSTEMATIC REVIEW AND META-ANALYSIS2021 Pediatric Critical Care Medicine conference-abstract Engineering Mechanical Circulatory Support Devices
Ariane Willems, Peter Paul Roeleveld, Marianne E. Nellis, Sonia Labarinas, Jennifer A. Muszynski, John W. W. Cyrus, +1 more
0citations -
PB1080 Clinical Course and Management of Patients with Emergency Surgeries Treated with Direct Oral Anticoagulants or Vitamin K Antagonists – Results of the German Prospective RADOA-Registry2023 Research and Practice in Thrombosis and Haemostasis conference-abstract Medicine Atrial Fibrillation Management and Outcomes Open access
Edelgard Lindhoff‐Last, Ingvild Birschmann, Simone Lindau, Stavros Konstantinides, Oliver Grottke, Ulrike Nowak‐Göttl, +7 more
0citations -
Abstract 13927: Advanced Age and Preferential Use of Vitamin K Antagonists in Severe Renal Impairment: First Results of the XARENO Registry in Patients With Non-valvular Atrial Fibrillation and Non-dialysis Dependent Advanced Chronic Kidney Disease
Reinhold Kreutz, Gilbert Deray, Juergen Floege, Marianne Gwechenberger, Andreas Rüdiger Luft, Hahn Kai, +2 more
0citations -
Prediction of Severe Gastrointestinal Bleeding Events in Hemodialysis: Collaborative Development of Machine Learning Model Within INSPIRE2021 Journal of the American Society of Nephrology conference-abstract Medicine Dialysis and Renal Disease Management
Suman Kumar Lama, Sheetal Chaudhuri, Joanna L. Willetts, John W. Larkin, Anke C. Winter, Manuela Stauss‐Grabo, +6 more
0citations -
PB0089 Anticoagulants after COVID-19 Pneumonia for Patients with Low Thrombotic Risk2023 Research and Practice in Thrombosis and Haemostasis conference-abstract Medicine COVID-19 Clinical Research Studies Open access
Tetyana Pertseva, Lyudmyla Konopkina, Nataliia Habshydze, Larysa Botvinikova, Olena Myronenko
0citations -
PB0120 Plasma Profiling of Patients on Vitamin K Antagonists Treatment: A Targeted Quantitative Proteomic Approach2023 Research and Practice in Thrombosis and Haemostasis conference-abstract Medicine Blood Coagulation and Thrombosis Mechanisms Open access
E. Camilleri, Bas van Vlijmen, Manfred Wuhrer, Suzanne C. Cannegieter, Nienke van Rein, Yassene Mohammed
0citations -
AB0383 EXTREME FATIGUE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND NEUROPSYCHIATRIC SYMPTOMS2020 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Lupus Erythematosus Research Open access
Rory Caitlin Monahan, Rolf Fronczek, Jeroen C.J. Eikenboom, Huub A. M. Middelkoop, L. J. J. Beaart- van de Voorde, Gisela Marie Terwindt, +4 more
0citations -
Subcutaneous amivantamab vs intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated, advanced non-small cell lung cancer (NSCLC): Primary results, including overall survival (OS), from the global, phase 3, randomized controlled PALOMA-3 trial.2024 Journal of Clinical Oncology conference-abstract Medicine Lung Cancer Treatments and Mutations Open access
Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna Rachel Minchom, Melina Elpi Marmarelis, +13 more
19citations -
MO514: Cardiorenal Outcomes Associated With Oral Anticoagulant Use in Patients With Atrial Fibrillation2022 Nephrology Dialysis Transplantation conference-abstract Medicine Atrial Fibrillation Management and Outcomes
Faizan Mazhar, Marco Trevisan, Paul Hjemdahl, Catherine M. Clase, Ype de Jong, Marie Evans, +3 more
0citations -
Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Vikas Gupta, John O Mascarenhas, Haris Ali, David M. Ross, Abdulraheem Yacoub, Tania Jain, +27 more
10citations